Our study demonstrates that blocking p53 activity also blocks CDK7-inhibition–induced GSDME overexpression (Figures 5A,C) and partially restores breast cancer cell proliferation and colony formation capacity from the suppressive effect of CDK7 inhibition. The gene discussed is TP53; the disease is breast cancer.